{
  "id": 101183,
  "name": "SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.)",
  "slug": "siemens-healthineers-fka-varian-medical-systems-inc",
  "state": "DC",
  "description": "Medical device manufacturer",
  "totalSpending": 1800000,
  "filings": 31,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 140000
    },
    {
      "year": 2019,
      "income": 220000
    },
    {
      "year": 2020,
      "income": 240000
    },
    {
      "year": 2021,
      "income": 240000
    },
    {
      "year": 2022,
      "income": 240000
    },
    {
      "year": 2023,
      "income": 240000
    },
    {
      "year": 2024,
      "income": 240000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "AKIN GUMP STRAUSS HAUER & FELD"
  ],
  "lobbyists": [
    "STEPHEN KHO",
    "BRIAN POMPER",
    "JUSTIN MCCARTHY",
    "BRENDAN DUNN",
    "FRANCINE FRIEDMAN",
    "CHRISTINA HALEY",
    "CHRISTOPHER TREANOR",
    "CASEY HIGGINS",
    "CARYN LESTER",
    "VIC FAZIO",
    "JULIE NOLAN",
    "LAUREN O'BRIEN",
    "GEOFF VERHOFF",
    "VIRGIL MILLER",
    "HEIDE BAJNRAUH",
    "JOSE BORJON",
    "SAM OLSWANGER",
    "LOUIS AGNELLO",
    "SEAN FEELY",
    "GALEN ROEHL",
    "MICHAEL BARNARD",
    "ANNA ABRAM",
    "FILEMON VELA",
    "ED PAGANO",
    "ERIC ETTORRE",
    "MIA HECK",
    "JOCELYN WILES",
    "KELLY ANN SHAW"
  ],
  "issues": [
    "TRD",
    "HCR",
    "MMM",
    "BUD",
    "CPT",
    "CSP",
    null,
    "TAX"
  ],
  "sampleDescriptions": [
    "USTR 301 Action.",
    "USTR 301 action",
    "Issues relating to cancer radiotherapy treatment equipment.",
    "USTR 301 action.",
    "Issues relating to cyber-security, health information technology.",
    "Issues related to radiation therapy reimbursement and alternative payment models.",
    "Issues related to radiation therapy reimbursement and alternative payment models; extension of device updates; certification of rural providers.",
    "Issues related to USTR 301 action.",
    "Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth.",
    "Section 301 tariff exclusion",
    "US-Brazil CEO Forum; tracking executive orders on supply chains.",
    "General issues regarding access to cancer care and treatment.",
    "Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth.; issues related to COVID-19 testing.",
    "Section 301 tariff exclusion; issues regarding USTR and device used for cancer care and treatment",
    "Issues regarding U.S.-Africa trade.",
    "Issues related to Medicare reimbursement for oncology care and alternative payment models; issues related to telehealth; issues related to COVID-19 testing.",
    "Issues regarding access to cancer care and treatment.",
    "H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.",
    "Issues re: copyright and the Library of Congress",
    "H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 71,
  "trajectory": "growing",
  "yearsActive": 8,
  "avgAnnualSpending": 225000,
  "peakYear": 2020,
  "lobbyistCount": 28,
  "firmCount": 1,
  "issueCount": 7,
  "industry": "healthcare"
}